At ELRIG Drug Discovery 2021, James Robinson of AstraZeneca, detailed how deep learning can effectively be applied to high content image analysis. In his presentation, he gave real-life examples where deep learning has been applied to projects at AstraZeneca, with benefits such as:
Development of assays previously not feasible
Increased assay data robustness
Time savings due to automated analysis
Identification of novel phenotypes
Watch James' presentation to learn how deep learning helps automate image analysis and truly accelerates drug discovery.